Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Date: November 26, 2019.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: The purpose of this meeting is to bring together committee members, representing government agencies, patient advocacy groups, other voluntary health organizations, and patients and their families to update one another on progress relevant to the Action Plan for the Muscular Dystrophies and to coordinate activities and discuss gaps and opportunities leading to better understanding of the muscular dystrophies, advances in treatments, and improvements in patients' and their families' lives. Prior to the meeting, an agenda will be posted to the MDCC website: https://mdcc.nih.gov/.Start Printed Page 54913
Registration: To register please contact Emily Carifi: Emily.Carifi@nih.gov.
Join WebEx Meeting: Join Webex meeting, Meeting number (access code): 621 291 684, Meeting password: GBY8DRM3.
Join from a video system or application, Dial email@example.com, You can also dial 184.108.40.206 and enter your meeting number.
Join by phone, 1-650-479-3208 Call-in toll number (US/Canada), Global call-in numbers.
Place: National Institutes of Health, Neuroscience Center Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Glen Nuckolls, Ph.D., Program Director, NINDS/NIH, NSC Building, 6001 Executive Blvd., Rm 2203, Bethesda, MD 20892, 301-496-5876, firstname.lastname@example.org.
Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Dated: October 7, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-22240 Filed 10-10-19; 8:45 am]
BILLING CODE 4140-01-P